Glenmede Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $238K | Buy |
|
|||||
|
2024
Q2 | $228K | Buy |
|
|||||
|
2024
Q1 | $295K | Buy |
|
|||||
|
2023
Q4 | $245K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $208K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $235K | Buy |
|
|||||
|
2021
Q4 | $294K | Sell |
|
|||||
|
2021
Q3 | $532K | Buy |
|
|||||
|
2021
Q2 | $470K | Buy |
|
|||||
|
2021
Q1 | $240K | Sell |
|
|||||
|
2020
Q4 | $233K | Sell |
|
|||||
|
2020
Q3 | $215K | Sell |
|
|||||
|
2020
Q2 | $190K | Sell |
|
|||||
|
2020
Q1 | $184K | Hold |
|
|||||
|
2019
Q4 | $184K | Buy |
|
|||||
|
2019
Q3 | $33 | Sell |
|
|||||
|
2019
Q2 | $62 | Sell |
|
|||||
|
2019
Q1 | $89 | Buy |
|
|||||
|
2018
Q4 | $48 | Sell |
|
|||||
|
2018
Q3 | $1.88M | Sell |
|
|||||
|
2018
Q2 | $3.92M | Hold |
|
|||||
|
2018
Q1 | $3.82M | Hold |
|
|||||
|
2017
Q4 | $3.82M | Sell |
|
|||||
|
2017
Q3 | $3.78M | Sell |
|
|||||
|
2017
Q2 | $3.36M | Hold |
|
|||||
|
2017
Q1 | $3.36M | Sell |
|
|||||
|
2016
Q4 | $3.36M | Sell |
|
|||||
|
2016
Q3 | $3.68M | Hold |
|
|||||
|
2016
Q2 | $3.64M | Sell |
|
|||||
|
2016
Q1 | $3.48M | Buy |
|
|||||
|
2015
Q4 | $3.67M | Sell |
|
|||||
|
2015
Q3 | $2.9M | Buy |
|
|||||
|
2015
Q2 | $2.72M | Buy |
|
|||||
|
2015
Q1 | $2.75M | Buy |
|
|||||
|
2014
Q4 | $2.2M | Hold |
|
|||||
|
2014
Q3 | $2.07M | Buy |
|
|||||
|
2014
Q2 | $572K | Buy |
|